Platform
Features
Pricing
0 followers
Nephraegis Therapeutics is a biopharmaceutical company developing NPH-022 to prevent and treat Acute Kidney Injury (AKI).
Industries
Headquarters
Employees
Links
Full screen
Bryan F. Cox
View all (0)
This company has no teams yet
View all
HQ
0 positions, 0 job posts
Merck
277 followers
Amgen
273 followers
Revvity
8 followers
AtriCure
4 followers
Abbott
372 followers
Gilead Sciences
157 followers
Regeneron
124 followers
Illumina
78 followers
Agilent Technologies
Apollo Global Management
46 followers
Verily Life Sciences
45 followers
Explore companies